img

Global Human Alpha1-Proteinase Inhibitor Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Alpha1-Proteinase Inhibitor Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Alpha1-Proteinase Inhibitor (Human), is a sterile, stable, lyophilized preparation of highly purified human alpha1-proteinase inhibitor (A1-PI)
The global Human Alpha1-Proteinase Inhibitor market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Human Alpha1-Proteinase Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Human Alpha1-Proteinase Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Human Alpha1-Proteinase Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Human Alpha1-Proteinase Inhibitor include Takeda, Kamada, Talecris Biotherapeutics and CSL Behring, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Human Alpha1-Proteinase Inhibitor, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Human Alpha1-Proteinase Inhibitor by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Human Alpha1-Proteinase Inhibitor market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Human Alpha1-Proteinase Inhibitor market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Takeda
Kamada
Talecris Biotherapeutics
CSL Behring
By Type
0.5g
1g
By Application
Hospital
Pharmacy
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
UK
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Human Alpha1-Proteinase Inhibitor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Human Alpha1-Proteinase Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Alpha1-Proteinase Inhibitor sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Human Alpha1-Proteinase Inhibitor Definition
1.2 Market by Type
1.2.1 Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 0.5g
1.2.3 1g
1.3 Market Segment by Application
1.3.1 Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Human Alpha1-Proteinase Inhibitor Sales
2.1 Global Human Alpha1-Proteinase Inhibitor Revenue Estimates and Forecasts 2018-2034
2.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Human Alpha1-Proteinase Inhibitor Revenue by Region
2.3.1 Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2018-2024)
2.3.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2024-2034)
2.4 Global Human Alpha1-Proteinase Inhibitor Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Region
2.6.1 Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Region (2018-2024)
2.6.2 Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Manufacturers
3.1.1 Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Human Alpha1-Proteinase Inhibitor Sales in 2022
3.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers
3.2.1 Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Alpha1-Proteinase Inhibitor Revenue in 2022
3.3 Global Human Alpha1-Proteinase Inhibitor Sales Price by Manufacturers
3.4 Global Key Players of Human Alpha1-Proteinase Inhibitor, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Product Offered and Application
3.8 Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Type
4.1.1 Global Human Alpha1-Proteinase Inhibitor Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Type (2018-2034)
4.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Type
4.2.1 Global Human Alpha1-Proteinase Inhibitor Historical Revenue by Type (2018-2024)
4.2.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Revenue by Type (2024-2034)
4.2.3 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2034)
4.3 Global Human Alpha1-Proteinase Inhibitor Price by Type
4.3.1 Global Human Alpha1-Proteinase Inhibitor Price by Type (2018-2024)
4.3.2 Global Human Alpha1-Proteinase Inhibitor Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Application
5.1.1 Global Human Alpha1-Proteinase Inhibitor Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Application (2018-2034)
5.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Application
5.2.1 Global Human Alpha1-Proteinase Inhibitor Historical Revenue by Application (2018-2024)
5.2.2 Global Human Alpha1-Proteinase Inhibitor Forecasted Revenue by Application (2024-2034)
5.2.3 Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2034)
5.3 Global Human Alpha1-Proteinase Inhibitor Price by Application
5.3.1 Global Human Alpha1-Proteinase Inhibitor Price by Application (2018-2024)
5.3.2 Global Human Alpha1-Proteinase Inhibitor Price Forecast by Application (2024-2034)
6 North America
6.1 North America Human Alpha1-Proteinase Inhibitor Sales by Company
6.1.1 North America Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024)
6.1.2 North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024)
6.2 North America Human Alpha1-Proteinase Inhibitor Market Size by Type
6.2.1 North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2034)
6.2.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2034)
6.3 North America Human Alpha1-Proteinase Inhibitor Market Size by Application
6.3.1 North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2034)
6.3.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2034)
6.4 North America Human Alpha1-Proteinase Inhibitor Market Size by Country
6.4.1 North America Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2034)
6.4.3 North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Company
7.1.1 Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024)
7.1.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024)
7.2 Europe Human Alpha1-Proteinase Inhibitor Market Size by Type
7.2.1 Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2034)
7.2.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2034)
7.3 Europe Human Alpha1-Proteinase Inhibitor Market Size by Application
7.3.1 Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2034)
7.3.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2034)
7.4 Europe Human Alpha1-Proteinase Inhibitor Market Size by Country
7.4.1 Europe Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2034)
7.4.3 Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Human Alpha1-Proteinase Inhibitor Sales by Company
8.1.1 China Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024)
8.1.2 China Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024)
8.2 China Human Alpha1-Proteinase Inhibitor Market Size by Type
8.2.1 China Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2034)
8.2.2 China Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2034)
8.3 China Human Alpha1-Proteinase Inhibitor Market Size by Application
8.3.1 China Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2034)
8.3.2 China Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Human Alpha1-Proteinase Inhibitor Sales by Company
9.1.1 APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024)
9.1.2 APAC Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024)
9.2 APAC Human Alpha1-Proteinase Inhibitor Market Size by Type
9.2.1 APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2034)
9.2.2 APAC Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2034)
9.3 APAC Human Alpha1-Proteinase Inhibitor Market Size by Application
9.3.1 APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2034)
9.3.2 APAC Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2034)
9.4 APAC Human Alpha1-Proteinase Inhibitor Market Size by Region
9.4.1 APAC Human Alpha1-Proteinase Inhibitor Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Human Alpha1-Proteinase Inhibitor Revenue by Region (2018-2034)
9.4.3 APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales by Company
10.1.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Market Size by Type
10.2.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Market Size by Application
10.3.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Market Size by Country
10.4.1 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Human Alpha1-Proteinase Inhibitor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Takeda Human Alpha1-Proteinase Inhibitor Products and Services
11.1.5 Takeda Human Alpha1-Proteinase Inhibitor SWOT Analysis
11.1.6 Takeda Recent Developments
11.2 Kamada
11.2.1 Kamada Company Information
11.2.2 Kamada Overview
11.2.3 Kamada Human Alpha1-Proteinase Inhibitor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Kamada Human Alpha1-Proteinase Inhibitor Products and Services
11.2.5 Kamada Human Alpha1-Proteinase Inhibitor SWOT Analysis
11.2.6 Kamada Recent Developments
11.3 Talecris Biotherapeutics
11.3.1 Talecris Biotherapeutics Company Information
11.3.2 Talecris Biotherapeutics Overview
11.3.3 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Products and Services
11.3.5 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor SWOT Analysis
11.3.6 Talecris Biotherapeutics Recent Developments
11.4 CSL Behring
11.4.1 CSL Behring Company Information
11.4.2 CSL Behring Overview
11.4.3 CSL Behring Human Alpha1-Proteinase Inhibitor Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 CSL Behring Human Alpha1-Proteinase Inhibitor Products and Services
11.4.5 CSL Behring Human Alpha1-Proteinase Inhibitor SWOT Analysis
11.4.6 CSL Behring Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Alpha1-Proteinase Inhibitor Value Chain Analysis
12.2 Human Alpha1-Proteinase Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Alpha1-Proteinase Inhibitor Production Mode & Process
12.4 Human Alpha1-Proteinase Inhibitor Sales and Marketing
12.4.1 Human Alpha1-Proteinase Inhibitor Sales Channels
12.4.2 Human Alpha1-Proteinase Inhibitor Distributors
12.5 Human Alpha1-Proteinase Inhibitor Customers
13 Market Dynamics
13.1 Human Alpha1-Proteinase Inhibitor Industry Trends
13.2 Human Alpha1-Proteinase Inhibitor Market Drivers
13.3 Human Alpha1-Proteinase Inhibitor Market Challenges
13.4 Human Alpha1-Proteinase Inhibitor Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 0.5g
Table 3. Major Manufacturers of 1g
Table 4. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Human Alpha1-Proteinase Inhibitor Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2018-2024)
Table 8. Global Human Alpha1-Proteinase Inhibitor Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region (2024-2034)
Table 10. Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Region: 2018 VS 2022 VS 2034 (MT)
Table 11. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2018-2024) & (MT)
Table 12. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2018-2024)
Table 13. Global Human Alpha1-Proteinase Inhibitor Sales by Region (2024-2034) & (MT)
Table 14. Global Human Alpha1-Proteinase Inhibitor Sales Market Share by Region (2024-2034)
Table 15. Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Manufacturers (2018-2024) & (MT)
Table 16. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2018-2024)
Table 19. Global Human Alpha1-Proteinase Inhibitor Price by Manufacturers 2018-2024 (USD/Kg)
Table 20. Global Key Players of Human Alpha1-Proteinase Inhibitor, Industry Ranking, 2021 VS 2022
Table 21. Global Human Alpha1-Proteinase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Human Alpha1-Proteinase Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Alpha1-Proteinase Inhibitor as of 2022)
Table 23. Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Product Offered and Application
Table 25. Global Key Manufacturers of Human Alpha1-Proteinase Inhibitor, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2024) & (MT)
Table 28. Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2024-2034) & (MT)
Table 29. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Type (2018-2024)
Table 30. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Type (2024-2034)
Table 31. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Type (2018-2024)
Table 34. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Type (2024-2034)
Table 35. Human Alpha1-Proteinase Inhibitor Price by Type (2018-2024) & (USD/Kg)
Table 36. Global Human Alpha1-Proteinase Inhibitor Price Forecast by Type (2024-2034) & (USD/Kg)
Table 37. Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2024) & (MT)
Table 38. Global Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2024-2034) & (MT)
Table 39. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Application (2018-2024)
Table 40. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Application (2024-2034)
Table 41. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Application (2018-2024)
Table 44. Global Human Alpha1-Proteinase Inhibitor Revenue Share by Application (2024-2034)
Table 45. Human Alpha1-Proteinase Inhibitor Price by Application (2018-2024) & (USD/Kg)
Table 46. Global Human Alpha1-Proteinase Inhibitor Price Forecast by Application (2024-2034) & (USD/Kg)
Table 47. North America Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024) & (MT)
Table 49. North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2024) & (MT)
Table 50. North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2024-2034) & (MT)
Table 51. North America Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2024) & (MT)
Table 54. North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2024-2034) & (MT)
Table 55. North America Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Human Alpha1-Proteinase Inhibitor Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2018-2024) & (MT)
Table 61. North America Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2024-2034) & (MT)
Table 62. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024) & (MT)
Table 63. Europe Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2024) & (MT)
Table 65. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2024-2034) & (MT)
Table 66. Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2024) & (MT)
Table 69. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2024-2034) & (MT)
Table 70. Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Human Alpha1-Proteinase Inhibitor Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2018-2024) & (MT)
Table 76. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2024-2034) & (MT)
Table 77. China Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024) & (MT)
Table 78. China Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2024) & (MT)
Table 80. China Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2024-2034) & (MT)
Table 81. China Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2024) & (MT)
Table 84. China Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2024-2034) & (MT)
Table 85. China Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024) & (MT)
Table 88. APAC Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2024) & (MT)
Table 90. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2024-2034) & (MT)
Table 91. APAC Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2024) & (MT)
Table 94. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2024-2034) & (MT)
Table 95. APAC Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Human Alpha1-Proteinase Inhibitor Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Human Alpha1-Proteinase Inhibitor Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Human Alpha1-Proteinase Inhibitor Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Region (2018-2024) & (MT)
Table 101. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity by Region (2024-2034) & (MT)
Table 102. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Company (2018-2024) & (MT)
Table 103. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2018-2024) & (MT)
Table 105. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Type (2024-2034) & (MT)
Table 106. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2018-2024) & (MT)
Table 109. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Application (2024-2034) & (MT)
Table 110. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2018-2024) & (MT)
Table 116. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity by Country (2024-2034) & (MT)
Table 117. Takeda Company Information
Table 118. Takeda Description and Overview
Table 119. Takeda Human Alpha1-Proteinase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 120. Takeda Human Alpha1-Proteinase Inhibitor Product and Services
Table 121. Takeda Human Alpha1-Proteinase Inhibitor SWOT Analysis
Table 122. Takeda Recent Developments
Table 123. Kamada Company Information
Table 124. Kamada Description and Overview
Table 125. Kamada Human Alpha1-Proteinase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 126. Kamada Human Alpha1-Proteinase Inhibitor Product and Services
Table 127. Kamada Human Alpha1-Proteinase Inhibitor SWOT Analysis
Table 128. Kamada Recent Developments
Table 129. Talecris Biotherapeutics Company Information
Table 130. Talecris Biotherapeutics Description and Overview
Table 131. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 132. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Product and Services
Table 133. Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor SWOT Analysis
Table 134. Talecris Biotherapeutics Recent Developments
Table 135. CSL Behring Company Information
Table 136. CSL Behring Description and Overview
Table 137. CSL Behring Human Alpha1-Proteinase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 138. CSL Behring Human Alpha1-Proteinase Inhibitor Product and Services
Table 139. CSL Behring Human Alpha1-Proteinase Inhibitor SWOT Analysis
Table 140. CSL Behring Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Human Alpha1-Proteinase Inhibitor Distributors List
Table 144. Human Alpha1-Proteinase Inhibitor Customers List
Table 145. Human Alpha1-Proteinase Inhibitor Market Trends
Table 146. Human Alpha1-Proteinase Inhibitor Market Drivers
Table 147. Human Alpha1-Proteinase Inhibitor Market Challenges
Table 148. Human Alpha1-Proteinase Inhibitor Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Alpha1-Proteinase Inhibitor Product Picture
Figure 2. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Alpha1-Proteinase Inhibitor Market Share by Type in 2022 & 2034
Figure 4. 0.5g Product Picture
Figure 5. 1g Product Picture
Figure 6. Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Human Alpha1-Proteinase Inhibitor Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Human Alpha1-Proteinase Inhibitor Report Years Considered
Figure 11. Global Human Alpha1-Proteinase Inhibitor Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Human Alpha1-Proteinase Inhibitor Revenue 2018-2034 (US$ Million)
Figure 13. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Human Alpha1-Proteinase Inhibitor Sales Quantity 2018-2034 (MT)
Figure 15. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Human Alpha1-Proteinase Inhibitor Sales Quantity YoY (2018-2034) & (MT)
Figure 18. North America Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity YoY (2018-2034) & (MT)
Figure 20. Europe Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Human Alpha1-Proteinase Inhibitor Sales Quantity YoY (2018-2034) & (MT)
Figure 22. China Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity YoY (2018-2034) & (MT)
Figure 24. APAC Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity YoY (2018-2034) & (MT)
Figure 26. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Human Alpha1-Proteinase Inhibitor Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Human Alpha1-Proteinase Inhibitor Revenue in 2022
Figure 29. Human Alpha1-Proteinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2034)
Figure 32. Global Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2034)
Figure 34. North America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Company in 2022
Figure 35. North America Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Company in 2022
Figure 36. North America Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2034)
Figure 38. North America Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2034)
Figure 40. North America Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2018-2034)
Figure 41. North America Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Country (2018-2034)
Figure 42. United States Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Company in 2022
Figure 45. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Company in 2022
Figure 46. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2034)
Figure 48. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2034)
Figure 50. Europe Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2018-2034)
Figure 51. Europe Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 53. France Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 54. UK Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 57. China Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Company in 2022
Figure 58. China Human Alpha1-Proteinase Inhibitor Revenue Market Share by Company in 2022
Figure 59. China Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2034)
Figure 61. China Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2034)
Figure 63. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Company in 2022
Figure 64. APAC Human Alpha1-Proteinase Inhibitor Revenue Market Share by Company in 2022
Figure 65. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2034)
Figure 67. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2034)
Figure 69. APAC Human Alpha1-Proteinase Inhibitor Revenue Share by Region (2018-2034)
Figure 70. APAC Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 75. India Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Human Alpha1-Proteinase Inhibitor Revenue Share by Country (2018-2034)
Figure 84. Brazil Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Human Alpha1-Proteinase Inhibitor Revenue (2018-2034) & (US$ Million)
Figure 89. Human Alpha1-Proteinase Inhibitor Value Chain
Figure 90. Human Alpha1-Proteinase Inhibitor Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed